Doxorubicin-induced autophagy (Dox) plays a pro-survival role in pancreatic cancer cells; thus, the pharmacological inhibition of autophagy by QC or the silence of ATG5 enhances Dox-induced cancer cell death. This evidence concerns the gene ATG5 and cancer.